Personalized ‘cocktails’ of antibiotics, probiotics and prebiotics hold promise in treating IBS, pilot study finds
Personalized “cocktails” of antibiotics, probiotics and prebiotics hold great promise in the treatment of a common form of irritable bowel syndrome (IBS), according to research presented at the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27–30 April).
Facebook Comments
https://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.png00aajahttps://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.pngaaja2024-04-27 12:04:392024-04-27 12:04:39Personalized ‘cocktails’ of antibiotics, probiotics and prebiotics hold promise in treating IBS, pilot study finds
